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An inverse correlation was found between cellular transglutaminase activity and metastatic potential of four 
cloned cell lines derived from a primary nickel-induced rat rhabdomyosarcoma. Cellular transglutaminase 
activity as assessed with endogenous cellular protein or exogenous methylated casein was greatest in the 
clone F9-4/8 which is the least metastasizing. When the putrescine-binding capacity of one cellular derived 
protein - fibronectin - was examined with exogenous transglutaminase, it was found that the fibronectin 
derived from the clone F9-4/8 showed the lowest binding capacity compared with those from the other 
clones. However, when the overall binding capacity of cellular proteins from each cell line was examined 
no differences could be detected. The results are discussed in the light of the well-known role of fibronectin 
in cellular adhesion. 
Transglutaminase Polyamine 
1. INTRODUCTION 
Transglutaminase (TGase) (EC.2.3.2.13) cata- 
lyzes the acyl-transfer eaction of a r-carboxamide 
group derived from a peptide-bound glutamine 
residue to primary amine receptors, such as the 
cNH2 of peptide-bound lysine or primary NH2 of 
polyamines [l-2]. There are many lines of evidence 
in the literature showing that this enzyme may play 
a role in cell transformation. Indeed, it has been 
shown that: (i) transformed cells, in vitro, have 
significantly lower total TGase activity than their 
normal counterparts [181; (ii) the enzymic product, 
6-(y-glutamyl)lysine, is present in lower amounts in 
transformed cells than in normal cells [3]; (iii) the 
TGase activity measured in rat sarcoma primary 
tumours decreased 4-7-fold following detection of 
metastases in lung [4]. 
In view of these observations, the question could 
be asked whether differences in TGase activity do 
exist between metastasizing and non-metastasizing 
cells. 
Metastasis Fibronectin 
To answer this question the model chosen con- 
sisted of a primary nickel-induced rat rhabdomyo- 
sarcoma cell line and clones with different meta- 
static potential derived from this same cell line. 
These cells have been well characterized with 
respect to their in vivo and in vitro growth and 
tumorigenic and metastatic capacities [5]. We 
report here the results of investigations on the 
TGase activity of these clones along with the 
putrescine-binding capacity of cellular proteins. 
2. MATERIALS AND METHODS 
2.1. Materials 
[‘4C]Putrescine dihydrochloride ([l ,4-14C]tetra- 
methylenediamine dihydrochloride, spec. act. 
109 Ci/mol) was purchased from the Radio- 
chemical Center (Amersham, Bucks). Putrescine 
dihydrochloride (PUT), phenylmethanesulfonyl 
fluoride (PMSF) and casein were obtained from 
Sigma (St. Louis, MO). 
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2.2. Methods 
2.2.1, Preparation of dimethylcasein 
Dimethylcasein was prepared as described [6]. 
2.2.2. Purification of liver transglutaminase 
TGase was purified from guinea pig liver [7]. 
One unit corresponds to the amount of enzyme 
capable of inserting 2.1 nmol PUT into 114 pg 
methylcasein in the presence of 67 PM PUT for 1 h 
at 37°C. 
2.2.3. Preparation of fibronectin 
Fibronectin was purified from the culture media 
by precipitation with spermine [8] with the 
modifications in [9]. 
2.2.4. Cells 
The cells used were isolated from a primary 
nickel-induced rat rhabdomyosarcoma as de- 
scribed [5]. The parental tumor cells (9-4/O) were 
cloned in vitro, thus providing a series of cell lines 
among which we used a low metastasizing line 
(F9-4/8) and two high metastasizing lines 
(F9-4/15, F9-4/6). 
The number of lung metastasizing colonies of 
these cells after i.v. injection into the tail vein of 
rats has been shown to be [5]: 7 rt 3.2 for the 
parental cell line (9-4/O); 1 + 0.2 for the clone 
F9-4/8; 18 f 4.2 for the clone F9-4/6; 19 f 2.3 for 
the clone F9-4/14. 
Growth medium (Dulbecco) supplemented with 
10% fetal calf serum was used for the growth of all 
cells. Cells were grown in culture to subconfluence 
and dispersed using 0.25% trypsin, 2 mM EDTA. 
The suspensions were centrifuged for 10 min at 
1000 rpm. The supernatants were filtered on 
0.22pm filters and PMSF was added to a final 
concentration of 0.4 mM. The cell pellets were 
washed twice with PBS at 4°C. The cell pellets and 
culture media were stored at - 70°C until use. 
2.2.5. Preparation of homogenates from cells 
Cells were resuspended in 0.14 M NaCl contain- 
ing PMSF (0.4 mM final concentration) then 
disrupted by sonication in a Branson Sonifier 
(model S75, Dansbury, CT) fitted with a micro- 
probe, for 2 s at output 2. 
2.2.6. Cellular transglutaminase activity with 
endogenous protein or dimethylcasein as 
acceptor proteins 
To experimental tubes containing various quan- 
tities of cellular homogenate (500, 250, 125 or 
62.5 /rg) protein in 100~1 were added 30~1 [14C]- 
PUT (8 pCi, 172 nmol). Additions to the mixture 
were 114pg dimethylcasein dissolved in 80~1 of 
0.14 M NaCl, 0.01 M Tris-HCl (pH 7.5) or 80 ~1 
of this buffer alone. The reaction was initiated by 
the addition of calcium to a final concentration of 
7 mM in the presence of 1 mM DTT and the 
volume was adjusted to 230 ,ul with the Tris buffer. 
In both cases (presence or absence of dimethyl- 
casein) the controls contained all constituents ex- 
cept cellular proteins. 
After incubation for 1 h at 37°C with gentle 
shaking, 50 ~1 incubation mixture were spotted on- 
Table 1 
Endogenous transglutaminase ctivity of cellular proteins (125 pg) in the presence or absence of dimethylcasein 
Clone Parental Clone Clone 
F9-4/8 cell line F9-4/6 F9-4/14 
9-4/o 
Lung colonizing capacity 
(number of lung metastasis 10 weeks after 
i.v. injection of lo5 cells)” 
Endogenous transglutaminase activity 
(pmol PUT incorporated) 
In the absence of dimethylcasein 
In the presence of 114pg dimethylcasein 
a From [5] 
1 * 0.2 7 k 3.2 18 + 4.2 19 * 2.3 
9.7 1.4 0.7 0.4 
185.8 23.4 5.1 3.8 
Each value represents the average of duplicate determinations carried out in two different experiments 
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to a Whatman 3MM filter paper disc presoaked 
with 100~1 of 100 mM EDTA and treated as in 
[lOI. 
2.2.7. Putrescine-binding capacity of cellular 
proteins by action of exogenous 
transglutaminase 
To experimental tubes containing 200 sg cellular 
protein were added [14C]PUT (0.7 &i) in amounts 
ranging from 29 to 474pM. 6081 of purified 
guinea pig liver TGase (1 U) was added to the mix- 
ture. The reaction was initiated by the addition of 
calcium to a final concentration of 7 mM in the 
presence of 1 mM DTT. The volume was adjusted 
to 230~1 with the Tris buffer. The control con- 
tained all the constituents except cellular proteins 
(which were replaced by buffer). 
Incubation, sampling and washing procedures 
were performed as described [lo]. 
2.2.8. Putrescine-binding capacity of fibronectin 
purified from culture medium by action of 
exogenous transglutaminase 
To experimental tubes containing 3Opg fibro- 
nectin was added [14C]PUT (spec. act. 
1 Ci/O.2 mol) in amounts ranging from 158 to 
890,uM. TGase and calcium were added to the 
mixture as described before. One series of control 
tubes contained all reagents except fibronectin 
which was replaced by buffer. 
Incubation and further procedures were per- 
formed as stated above. 
3. RESULTS 
Kinetic evidence for the TGase reaction has 
clearly demonstrated that the amine enters the 
reaction sequence only after the formation of an 
acyl-enzyme intermediate between the acceptor 
protein (contributing for the acyl portion) and the 
enzyme [l]. The affinity for a given amine is then 
a function of the structure of the acyl portion of 
the first substrate. 
3.1. Reaction of endogenous transglutaminase 
with endogenous proteins (first substrate) 
In a first approach, the capacity of endogenous 
proteins from the different cloned cell lines to react 
with endogenous TGase was tested in the presence 
of excess PUT (67 PM) and CaCl2 (6 mM). The 
results (table 1) show that on the basis of their 
TGase activity, the clones can be classed: 
F9-4/8 > 9-4/O > 
F9-4/6 > F9-4/14. 
The enzymic activity of the low-metastasizing 
clone (F9-4/8) is around 5-7-times greater than 
that of the parental cells (9-4/O) whose TGase ac- 
tivity was itself I-3-fold greater than that of clone 
F9-4/6 and 4-6-fold greater than that of clone 
F9-4/14 both of which are highly metastasizing. 
As differences in the enzyme itself and/or accep- 
tor proteins may contribute to these results, the ex- 
periment was repeated in the presence of excess ex- 
ogenous protein, dimethylcasein, as first substrate. 
3.2. Reaction of endogenous transglutaminase in 
the presence of an exogenous protein - 
dimethylcasein (first substrate) 
In the presence of dimethylcasein (114pg), the 
TGase activity is greater with extracts from all 4 
clones than that observed with endogenous pro- 
teins only (125 pg). As shown in table 1, PUT 
bound to protein in the presence of dimethylcasein 
(Vn) vs that in its absence (VA) increased 7-fold for 
clone F9-4/6, 9.5-fold for clone F9-4/14, 17-fold 
for parental cells and 19-fold for clone F9-4/8. 
Nevertheless, in terms of their TGase activity the 
order of the clones remains the same: F9-4/8 > 
9-4/O > F9-416 > F9-4/14. Thus differences in ac- 
ceptor protein are not responsible for the dif- 
ferences in enzyme activity. To obtain further 
evidence for differences in enzyme activity, in- 
creasing quantities of enzyme derived from each of 
the 4 clones were added to excess dimethylcasein 
and the amount of bound putrescine measured. 
It is apparent (fig. 1) that TGase activity is again 
in the order: F9-4/8 > 9-4/O> F9-4/6 > F9-4/14. 
It is interesting to note that in the case of clones 
F9-416 and F9-4/14 enzyme activity increases 
linearly with enzyme concentrations up to 500 pg 
(cellular proteins) whereas, in the case of the 
parental cells 9-4/O and clone F9-4/8 the slope 
changes from 25Opg protein onwards. If these 
results provided strong evidence for diminished 
TGase activity per se in the highly metastatic line 
F9-4114, compared to that in the least metastatic 
F9-418, they provided no answer to the question 
raised by the results in table 1 concerning the 
availability of r-carboxamide groups in glutamine 
residues of endogenous proteins of the different 
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Fig. 1. Endogenous transglutaminase activity (dimethyl- 
casein) as exogenous ubstrate) of various quantities of 
cellular proteins from: (A) clone F9-4/S, (*) parental 
cell line 9-4/O, (A) clone F9-4/6, (w) clone F9-4/14. 
clones. To investigate this h~othesis, the PUT- 
binding capacity of cellular proteins was in- 
vestigated in the presence of exogenous TGase 
purified from guinea pig liver. 
3.3. PUT ~~~~ing of ce~i~~ar pretests by a~l~~~ of 
exogemus tru~sgl~ta~~~ase 
The highest activity of endogenous TGase was 
0.18 nmol PUT/l 14 pg dimethylcasein. In order 
to have exogenous TGase in excess, a quantiry of 
enzyme which permits the insertion of 2.1 nmol 
PUT/114pg dimethylcasein in the presence of 
67 @M PUT was chosen. Under these experimental 
conditions, the exogenous enzyme was present in 
an at least 1 l-fold excess over endogenous enzyme. 
Therefore, the maximum acceptor capacity (ap- 
parant V,,,) of the Gln residue of cellular proteins 
could be assessed by performing the reaction in the 
presence of PUT in increasing quantities 
(29-474pM), cellular proteins at a fixed concen- 
tration (2~~g) and excess enzyme. As illustrated 
in table 2, the apparent V,,, of the PUT-binding 
capacity of cellular proteins was not significantly 
different between clones F9-4/6, F9-4/S and 
parental cells. As all cellular acceptor proteins are 
present simultaneously, it is not possible to deter- 
mine the relative contribution of each protein to 
the overall reaction velocity. However, one cellular 
protein, fibronectin, influences cell adhesion to 
collagenous matrices [l I] and modulates the me- 
tastatic activity of melanoma cells [12]. Further- 
more, fibronectin purified from the culture 
medium of transformed celis compared with that 
of normal cells presented ifferences in polyamine 
acceptor capacity with exogenous TGase and 
Table 2 
Putrescine-binding capacity of cellular proteins by ac- 
tion of exogenous transglu~a~in~e 
Cell line vln,, @PP.) 
(pmol PUT bound per 
200 jig cellular proteins) 
Parental cells 122 jc 20 
F9-4/6 139 It 39 
F9-4f8 161 zk44 
Each value represents the average of duplicate deter- 
minations carried out in two different experiments 
Table 3 
Putresci~e-binding capacity of fibrone~tin (purified 
from cell culture medium) by action of exogenous trans- 
glutaminase 
30 pg fibronectin purified 
from ceI1 medium culture 
of 
% of PUT-binding 
capacity 
Paren&ai cells: Q-4/0 100 *s 
F9-4/6 87.5 + 2.2 
F9-4/14 95.0 f 5.0 
F9-41’8 73.9 rt 1.9 
Each value represents the average of duplicate deter- 
minations carried out in two different experiments. 
100% =I 1240 pmol PUT bound/30pg fibronectin cor- 
responding to the apparent V,, 
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bound polyamines which are more accessible to an- 
tipolyamine antibodies [9]. It therefore seemed 
reasonable to compare the PUT-binding capacity 
of fibronectin released from the different cell lines. 
3 4. PUT-binding capacity of fibronectin purified 
from cell culture medium by action of 
exogenous transglutaminase 
Fibronectin (3Opg) purified from the cell 
medium culture of each cell line was incubated 
with excess exogenous TGase and PUT 
(132-660 /rM) as described in section 2. The results 
of these experiments (table 3) show that the pro- 
tein-bound glutamine of the fibronectin released 
by clone F9-4/8 has the lowest binding capacity 
compared to the fibronectin from the other clones- 
4. DISCUSSION 
Our results provide evidence that cell lines with 
a high metastatic potential on intravenous injec- 
tion into rats exhibit low transglutaminase activity. 
As all 4 clones were derived from the same rat 
rhabdomyosarcoma parental cell line, differences 
in enzyme activity reflect some intrinsic property 
of the clones and not differences in tissue specifici- 
ty. Furthermore, as enzyme assays were performed 
on homogenates from cells which had all reached 
confluence prior to harvesting, fluctuations in en- 
zyme activity with growth rate could be reasonably 
eliminated. 
As regards enzyme activity itself, it was always 
in the order of greatest activity in the least meta- 
static to the lowest activity in the most metastatic 
(table 1) regardless of whether endogenous or ex- 
ogenous protein (dimethylcasein) was used as ac- 
ceptor protein. This observation rules out the 
possibility that differences in acceptor protein 
availability might have been responsible for dif- 
ferences in endogenous enzyme activity. We are 
therefore left with the possibilities that there are 
different amounts of either transglutaminase itself 
or of modulators of the enzyme in the clones 
F9-4/8. Our results do not permit us to choose be- 
tween these two hypotheses but the resultant activi- 
ty on combining homogenates derived from clones 
with high and low transglutaminase activities 
should allow a choice to be made. 
Irrespective of the reason for the reduced activi- 
ty, our results not only confirm those previously 
reported [4] showing a decrease in transglu- 
taminase activity in the primary tumour with me- 
tastasizing cells compared to that without such 
metastasis, but they extend the validity of this 
finding to cell lines with different metastatic poten- 
tial. 
It should also be recalled that the decrease in 
cellular transglutaminase which takes place on cell 
transformation is accompanied by a change in its 
intracellular distribution. The enzyme becomes 
localised primarily on the membrane in hepatomas 
as compared to its cytosolic localisation in 
regenerating hepatocytes [131. This redistribution 
could be responsible for the altered polyamine- 
binding capacity of at least one membrane protein 
- fibronectin. In accordance with this interpreta- 
tion is the result that the lowest polyamine-binding 
capacity of fibronectin was found with that de- 
rived from clone F9-4/8 which has the highest 
transglutaminase activity. In contrast, when total 
cellular proteins were used, no differences in poly- 
amine-binding capacity could be detected among 
the 4 clones. Taken together, these results do not 
rule out the possibility that in addition to fibronec- 
tin there may be other proteins with different bind- 
ing capacities but rather suggest that the dif- 
ferences are masked when all the proteins are ex- 
amined together. 
Fibronectin is one of the proteins involved in cell 
adhesion [14,15] and differences similar to those 
reported here had previously been reported for 
fibronectin derived from normal rat kidney cells 
and from normal rat kidney cells transformed by 
Rous Sarcoma virus [9]. 
One mechanism which could explain the role of 
fibronectin in promoting cell adhesion is that in- 
volving the formation of isopeptide bonds between 
glutamine residues of fibronectin and lysine groups 
of collagen [1 I]. 
The accessibility of these glutamine residues 
could be reduced by conformational changes 
brought about by post-translational modifications 
such as phosphorylation [ 151, glycosylation [ 161 
and sulphation [ 171. Our results suggest hat trans- 
glutamination may be another such post-trans- 
lational modification which could give rise to 
fibronectins with y-carboxamides already in iso- 
peptide linkages. The determination of the number 
of isopeptide bonds in the fibronectins from the 
different clones should provide a direct answer. 
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